- January 2019
- October 2018
- September 2018
- July 2018
- June 2018
- May 2018
- November 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- December 2016
- November 2016
- September 2016
- August 2016
- June 2016
- May 2016
- March 2016
- October 2015
- June 2015
- May 2015
- April 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- June 2014
- March 2014
- December 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- November 2012
- October 2012
- July 2012
- June 2012
- May 2012
- April 2012
- November 2011
- July 2011
- December 2010
- By wichlab on January 9, 2019Read more
The paper describes the development of a double responsive polysaccharide-based material that effectively transports photoactive therapeutics into cells.
B. Breitenbach, E. Steiert, M. Konhäuser, L.-M.Vogt, Y. Wang, S. H. Parekh and P. R. Wich, Soft Matter, 2019, just accepted.
- By wichlab on October 12, 2018Read more
Great job Dr. Ira! Congratulations and all the best for your future endeavours!
- By wichlab on September 20, 2018Read more
The paper describes the stepwise development of a nanocapsule for vaccination approaches, comprising a shell consisting of antigen and loaded with a superadditive adjuvant combination.
D. Paßlick, K. Piradashvili, D. Bamberger, M. Li, S. Jiang, D. Strand, P. R. Wich, K. Landfester, S. Grabbe, M. Bros, V. Mailänder, J. Controlled Release. 2018, just accepted
- By wichlab on July 24, 2018Read more
He was selected as one of 20 participants of the Leibniz Young Polymer Scientist Forum, organized by DWI and Evonik Industries in Aachen (June 28 – 29, 2018)
Benjamin was part the winning team that received the Evonik Young Scientist Award. Their project “Deligel” describes a nutraceutical, which releases several supplements specifically. This system could be an option for people with swallowing difficulties.
- By wichlab on July 9, 2018Read more
We are looking for enthusiastic and dedicated new team members who enjoy science and are excited about new challenges.
Interested students in the field of chemistry, chemical engineering, biomedicinal chemistry, material science (and neighboring fields) who would like to join the WichLab as PhD students in Australia are welcome to send their applications via email, the contact form on our website or drop by…
- By wichlab on June 5, 2018Read more
The paper describes the double emulsion preparation of nanoparticles that carry enzymes with antibacterial activity. It is the first reported example where both payload and carrier material are protein-biopolymers.
E. Steiert, L. Radi, M. Fach, P. R. Wich, Macromol. Rapid Commun. 2018, 1800186
Peter started new position as Senior Lecturer at the University of New South Wales (Sydney, Australia)By wichlab on June 1, 2018Read more
We are excited to announce that we opened our research labs at the School of Chemical Engineering this June!
For some time, we will run our labs in Germany and Australia in parallel and part of the group will remain involved at the Institute for Pharmacy and Biochemistry at the Johannes Gutenberg-University in Mainz (Germany).
- By wichlab on May 9, 2018Read more
Lydia successfully defended her PhD work! Congratulations and all the best for your future endeavours. The wichlab will miss you!
- By wichlab on November 23, 2017Read more
The award was given for the complete revision of the German textbook “Beyer/Walter: Organische Chemie”.
The literature prize was given to the three authors Tanja Schirmeister (JGU Mainz), Carsten Schmuck (University Duisburg-Essen, and Peter Wich (JGU Mainz) during the “200th Kuratorium-Sitzung” of the FCI, hosted this year at the Evonik headquarters in Essen.
- By wichlab on November 15, 2017Read more
The paper describes the surface modifications of sugar-based nanoparticles and the influence on immunostimmulatory effects. It is the first paper that shows that DEXylated particles can potentially be used for passive targeting of antigen presenting cells for future immunotherapeutic applications.
D. Bamberger, D. Hobernik, M. Konhäuser, M. Bros and P. R. Wich, Mol. Pharmaceutics 2017, ASAP.